Page 56 - 2021 Taiwan Food and Drug Administration Annual Report
P. 56

DEXVH  XULQH  VDPSOH  WHVWV   WHVWV  SHUIRUPHG         15 institutions in Taiwan at present to help
    with non-urine specimens in suspected drug             SURVHFXWLRQ  SROLFH  DQG LQYHVWLJDWLRQ DXWKRULWLHV 
    DQG  FRQWUROOHG  GUXJ  FDVHV   GUXJ  VHL]HG   HWF      test non-urine specimens for drug abuse. In
    and monthly compiled into the “Drug Abuse              accordance with Article 9-3 of the “Enforcement
    &DVH DQG 7HVWLQJ 6WDWLVWLFV ´                          Rules of Narcotics Hazard Prevention Act,´ 
                                                           each inspection agency and institution should
    Implementation Strategy                                report drug test results to the UDARS every
                                                           month. TFDA will count positive results of non-
    I. Reporting mechanism for                             urine samples of suspected drug and controlled
      healthcare facilities on drug                        drug cases on a monthly basis to provide
      abuse                                                reference for the development of drug control
                                                           strategies by various departments.
       TFDA has established a Drug Abuse
    Reporting System (DARS) to receive                     IV. Taiwan Emergency Depart-
    information through drug abuse cases                      ment Drug Abuse Surveillance
    reported monthly by healthcare facilities in
    WKH  FRXQWU\   WR  REWDLQ  WKH  HSLGHPLRORJLFDO            ,Q         7)'$  FRPPLVVLRQHG  WKH  ³5HLQ-
    information of drug abuse cases.                       forced Monitoring Plan for NPS in Emergen-
                                                           F\  'HSDUWPHQWV   (' ´  WR  FRQGXFW  H[SDQGHG 
    II. Management and reporting of                        screening of urine samples of 150 NPS for
       approved institutions for drug                      suspected drug poisoning cases in ED of med-
       abuse urine tests                                   ical institutions across the country. The results
                                                           of the expanded screening can be the reference
       $V  RI  WKH  HQG  RI         WKHUH  ZHUH            to diagnosis and treatment for emergency phy-
    approved institutions for drug abuse urine             VLFLDQV  DV ZHOO DV WKH UHIHUHQFH IRU GUXJ DEXVH 
    tests and designated testing institutions in           situation in country’s EDs.
    the country. The approved testing institutions
    will regularly submit the inspection results           $FKLHYHPHQWV DQG %HQH¿WV
    to the Urine Test for Drug Abuse Reporting
    System (UDARS) on a monthly basis.                     I. Reporting situation of drug
    TFDA conducted performance monitoring of                 abuse at healthcare facilities
    approved institutions on a quarterly basis. In
          D WRWDO RI    FDVHV ZHUH KDQGOHG                    The analysis data of DARS showed that
                                                           WKHUH  ZHUH          FDVHV  LQ  WRWDO  UHSRUWHG 
    III. Non-urine (Drug) testing and                      for drug abuse by healthcare facilities in
       reporting upon drug abuse                           2020. The top three types of drug abuse case
                                                           QXPEHU  LQFOXGHG  KHURLQ                    
        According to the division of labor in drug          PHWK   DPSKHWDPLQH                    DQG 
    WHVWLQJ  RI  WKH  0LQLVWU\  RI  -XVWLFH   WKHUH  DUH 

54
   51   52   53   54   55   56   57   58   59   60   61